Skip to main content

HB 153 — Kentucky

AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.

Introduced 2026RS session House

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.

Official abstract, as published by the legislature.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: L. Willner, C. Aull, S. Bratcher, B. Chester-Burton, K. Fleming, D. Grossberg, V. Grossl, C. Lewis, K. Moser, J. Nemes, R. Roarx, S. Stalker

History

  1. Introduced, completed
  2. Passed House, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House introduced in House Milestone
  2. House to Committee on Committees (H)
  3. House to Health Services (H) Latest

Source: Open States. Last checked November 9, 2026. How we keep this accurate ›